- Home
- VMAR vs ATXI Comparison
VMAR vs ATXI Comparison
Compare VMAR & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- ATXI
- Stock Information
- Founded
- VMAR 1995
- ATXI 2015
- Country
- VMAR Canada
- ATXI United States
- Employees
- VMAR N/A
- ATXI N/A
- Industry
- VMAR Marine Transportation
- ATXI Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- ATXI Health Care
- Exchange
- VMAR Nasdaq
- ATXI Nasdaq
- Market Cap
- VMAR 2.8M
- ATXI 3.0M
- IPO Year
- VMAR 2020
- ATXI 2017
- Fundamental
- Price
- VMAR $1.50
- ATXI $1.84
- Analyst Decision
- VMAR Strong Buy
- ATXI
- Analyst Count
- VMAR 1
- ATXI 0
- Target Price
- VMAR $270.00
- ATXI N/A
- AVG Volume (30 Days)
- VMAR 706.6K
- ATXI 26.2K
- Earning Date
- VMAR 01-14-2025
- ATXI 11-14-2024
- Dividend Yield
- VMAR N/A
- ATXI N/A
- EPS Growth
- VMAR N/A
- ATXI N/A
- EPS
- VMAR N/A
- ATXI N/A
- Revenue
- VMAR $2,811,751.00
- ATXI N/A
- Revenue This Year
- VMAR $120.43
- ATXI N/A
- Revenue Next Year
- VMAR N/A
- ATXI N/A
- P/E Ratio
- VMAR N/A
- ATXI N/A
- Revenue Growth
- VMAR N/A
- ATXI N/A
- 52 Week Low
- VMAR $1.30
- ATXI $1.60
- 52 Week High
- VMAR $162.00
- ATXI $26.48
- Technical
- Relative Strength Index (RSI)
- VMAR 26.29
- ATXI 44.82
- Support Level
- VMAR $1.30
- ATXI $1.80
- Resistance Level
- VMAR $1.83
- ATXI $1.88
- Average True Range (ATR)
- VMAR 0.24
- ATXI 0.13
- MACD
- VMAR 0.08
- ATXI -0.01
- Stochastic Oscillator
- VMAR 14.08
- ATXI 40.70
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.